Approximately one year ago DNA 2.0 filed a lawsuit against Genome Compiler accusing the corporation of infringing certain patent agreements granted to DNA 2.0 in 2010. Just recently, the two companies reached a settlement in that Genome Compiler is permitted a license for the use of the patented technology. This judicial decision has created a small amount of hope for other companies using bioCAD software; altruistically allowing them access to the use of this design tool, and potential design tools, in the future.
For the “smaller” big picture view on how the dispute between Genome Compiler and DNA2.0 affects the synthetic biology industry, I’d say the industry can breathe a collective sigh of relief for now. Just remember that this won’t be the last time a patent dispute summons lawyers to the bargaining table, software or otherwise.
Read the article Here
(2) Readers Comments
April 08, 2014
January 12, 2014
March 24, 2014
Nice post. I learn something totally new and challenging on sites I
Heya i'm for the first time here. I found this board and I to find It
Saved as a favorite, I really like your website!
I don't even know how I ended up here, but I thought this post was g
Thanks for sharing your thoughts about bottle. Regards